GSK Aktie
22,11
EUR
+0,33
EUR
+1,52
%
20,26
CHF
+0,41
CHF
+2,04
%
Erwachsen handeln.
Mit dem Broker, der Top-Insights, geprüfte Analysen
und Trading ab 0 € vereint (zzgl. Spreads).
Werbung
GSK Aktie Analyse
| 26.07.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 19.07.12 | GSK outperform | Exane-BNP Paribas SA | |
| 19.07.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 18.07.12 | GSK buy | Banc of America Securities-Merrill Lynch | |
| 18.07.12 | GSK neutral | Credit Suisse Group | |
| 18.07.12 | GSK neutral | Nomura | |
| 17.07.12 | GSK verkaufen | Hamburger Sparkasse AG (Haspa) | |
| 17.07.12 | GSK halten | Independent Research GmbH | |
|
Werbung
|
|||
| 17.07.12 | GSK neutral | Sarasin Research | |
| 13.07.12 | GSK hold | Deutsche Bank AG | |
| 12.07.12 | GSK neutral | J.P. Morgan Cazenove | |
| 10.07.12 | GSK buy | UBS AG | |
| 09.07.12 | GSK halten | Independent Research GmbH | |
| 05.07.12 | GSK hold | Deutsche Bank AG | |
| 03.07.12 | GSK buy | Citigroup Corp. | |
| 03.07.12 | GSK neutral | J.P. Morgan Cazenove | |
| 03.07.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 28.06.12 | GSK hold | Deutsche Bank AG | |
| 21.06.12 | GSK neutral | Credit Suisse Group | |
| 20.06.12 | GSK buy | Citigroup Corp. | |
| 19.06.12 | GSK outperform | Exane-BNP Paribas SA | |
| 11.06.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 08.06.12 | GSK buy | Citigroup Corp. | |
| 07.06.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 05.06.12 | GSK neutral | Credit Suisse Group | |
| 04.06.12 | GSK buy | Citigroup Corp. | |
| 31.05.12 | GSK buy | UBS AG | |
| 30.05.12 | GSK hold | Deutsche Bank AG | |
| 10.05.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 04.05.12 | GSK neutral | J.P. Morgan Cazenove | |
| 04.05.12 | GSK halten | Independent Research GmbH | |
| 02.05.12 | GSK verkaufen | Hamburger Sparkasse AG (Haspa) | |
| 26.04.12 | GSK neutral | Sarasin Research | |
| 23.04.12 | GSK neutral | Nomura | |
| 11.04.12 | GSK buy | UBS AG | |
| 04.04.12 | GSK neutral | J.P. Morgan Cazenove | |
| 03.04.12 | GSK neutral | J.P. Morgan Cazenove | |
| 02.04.12 | GSK outperform | Exane-BNP Paribas SA | |
| 27.03.12 | GSK neutral | J.P. Morgan Cazenove | |
| 23.02.12 | GSK neutral | J.P. Morgan Cazenove | |
| 09.02.12 | GSK neutral | J.P. Morgan Cazenove | |
| 09.02.12 | GSK neutral | Credit Suisse Group | |
| 08.02.12 | GSK buy | UBS AG | |
| 08.02.12 | GSK halten | Independent Research GmbH | |
| 08.02.12 | GSK verkaufen | Hamburger Sparkasse AG (Haspa) | |
| 08.02.12 | GSK buy | UBS AG | |
| 08.02.12 | GSK equal-weight | Morgan Stanley | |
| 08.02.12 | GSK neutral | Sarasin Research | |
| 06.02.12 | GSK buy | Banc of America Securities LLC | |
| 03.02.12 | GSK neutral | Nomura | |
Werbung
Werbung